Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-19

Clinical Trial Update: Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial. [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial comparing 1.2% atorvastatin gel versus 1.2% simvastatin gel as local drug delivery in chronic periodontitis patients with diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atorvastatin gel (1.2%) (atorvastatin)
  • simvastatin gel (1.2%) (simvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis Wth Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED